地塞米松在胶质瘤围手术期管理中的安全性与疗效
该单中心回顾性队列研究纳入435例2014至2019年间接受原发性胶质瘤切除术的患者,评估地塞米松对术后并发症和总生存的影响。结果发现术前和术后联合使用地塞米松有术后伤口感染增加的趋势(3% vs 0%,p=0.082),地塞米松使用与死亡风险增加相关(总体p=0.017),术前单独使用风险比3.0(p=0.062)。
要点
- 术前和术后联合使用地塞米松有术后伤口感染增加的趋势。
- 地塞米松使用与死亡风险增加相关,术前使用影响可能最明显。
- 使用地塞米松需权衡潜在严重不良后果。
核心结论
- 术前和术后联合使用地塞米松可能增加术后伤口感染风险。
- 地塞米松使用,特别是术前使用,可能对生存产生负面影响。
研究设计与样本
- 单中心回顾性队列研究,纳入435例2014至2019年间接受原发性胶质瘤切除术的患者。
主要发现
- 术前和术后联合使用地塞米松者术后伤口感染发生率为3%,单次使用或未使用者为0%(p=0.082)。
- 地塞米松使用与新发高血糖无关(p=0.149)。
- 多因素Cox比例风险分析显示地塞米松使用与死亡风险增加相关(总体p=0.017)。
- 术前单独使用地塞米松的风险比为3.0(p=0.062)。
临床怎么用
- 胶质瘤围手术期使用地塞米松时应警惕伤口感染和生存期缩短的潜在风险。
局限性
- 本研究为单中心回顾性队列研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In this single-institution retrospective cohort study, the authors evaluated the effect of dexamethasone on postoperative complications and overall survival in patients with glioma undergoing resection. METHODS: A total of 435 patients who underwent resection of a primary glioma were included in this retrospective cohort study. The inclusion criterion was all patients who underwent resection of a primary glioma at a tertiary medical center between 2014 and 2019. RESULTS: The use of both pre- and postoperative dexamethasone demonstrated a trend toward the development of postoperative wound infections (3% vs 0% in single use or no use, p = 0.082). No association was detected between dexamethasone use and the development of new-onset hyperglycemia (p = 0.149). On multivariable Cox proportional hazards analysis, dexamethasone use was associated with a greater hazard of death (overall p = 0.017); this effect was most pronounced for preoperative (only) dexamethasone use (hazard ratio 3.0, p = 0.062). CONCLUSIONS: Combined pre- and postoperative dexamethasone use may increase the risk of postoperative wound infection, and dexamethasone use, specifically preoperative use, may negatively impact survival. These findings highlight the potential for serious negative consequences with dexamethasone use.
引用
- Medikonda R, Patel K, Jackson C, et al. The safety and efficacy of dexamethasone in the perioperative management of glioma patients. J Neurosurg. 2021. PMID: 34560653. doi:10.3171/2021.4.JNS204127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。